Current landscape and clinical progress of targeted alpha radioimmunotherapy
American Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.62347/getq4987 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Owen C Booth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA.
- Department of Radiation Oncology, Indiana University School of Medicine Indianapolis, IN, USA.
- Advanced Molecular Imaging Research Laboratory, Purdue University West Lafayette, IN, USA.
Zitieren
APA
Booth, O. C., Dhamecha, K. R., Oderinde, O. M., & Zheng, Q. H. (2025). Current landscape and clinical progress of targeted alpha radioimmunotherapy. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/getq4987
Vancouver
Booth OC, Dhamecha KR, Oderinde OM, Zheng QH. Current landscape and clinical progress of targeted alpha radioimmunotherapy. American Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.62347/getq4987
BibTeX
@article{Booth2025,
author = {Booth, Owen C and Dhamecha, Karena R and Oderinde, Oluwaseyi M and Zheng, Qi-Huang},
title = {Current landscape and clinical progress of targeted alpha radioimmunotherapy},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.62347/getq4987}
}
EUVIMED